Shivalik Rasayan Ltd

Shivalik Rasayan maintains a conservative capital structure with a debt-to-equity ratio of 0.15, significantly below the industry median of 0.45, indicating a low reliance on debt financing. The company's liquidity position is characterized as medium risk, with a current ratio of 1.85, which is in line with the industry median of 1.80. However, the operating cash flow of -INR 80.75 million and a negative net cash position after subtracting total debt raise concerns about short-term liquidity. Profitability metrics for Shivalik Rasayan are below the industry benchmarks. The company's return on equity (ROE) of 0.71% is well below the industry median of 4.2%, and its return on assets (ROA) of 0.52% is also below the median of 1.8%. These figures suggest that the company is underperforming in terms of capital efficiency and asset utilization. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes in the agricultural sector. The absence of segment-specific revenue data limits the ability to assess the performance of individual product lines or geographic regions. Shivalik Rasayan's growth trajectory is constrained by its current financial performance. The company's operating income of INR 63.07 million and net income of INR 35.98 million indicate limited profitability. With capital expenditures of -INR 676.56 million, the company is investing heavily in infrastructure, which may impact short-term earnings but could support long-term growth. The risk assessment highlights liquidity as a medium concern, primarily due to the negative operating cash flow and the absence of a strong cash buffer. The dilution risk is classified as low, with no significant dilution events reported in the latest filings. However, the company's reliance on capital expenditures without a corresponding increase in operating cash flow could lead to future dilution pressures. Recent filings and transcripts do not indicate any major strategic shifts or new product launches. The company's focus remains on expanding its production capacity and maintaining its position in the domestic agricultural chemicals market.